Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62.7M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$43.7M |
| 3 |
AvalonBay Communities
AVB
|
+$36.7M |
| 4 |
Simon Property Group
SPG
|
+$36.4M |
| 5 |
AGNC Investment
AGNC
|
+$35.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$52.7M |
| 2 |
Cencora
COR
|
+$39.6M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$35.8M |
| 4 |
TLM
TALISMAN ENERGY INC
TLM
|
+$30M |
| 5 |
Ecolab
ECL
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.29% |
| 2 | Technology | 14.5% |
| 3 | Industrials | 10.63% |
| 4 | Consumer Discretionary | 9.8% |
| 5 | Consumer Staples | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1701
DELISTED
Esperion Therapeutics
ESPR
| $1.17M | ﹤0.01% |
14,300
+1,600
| +13% | +$157K |
|
1702
Lesaka Technologies
LSAK
$416M
| $1.16M | ﹤0.01% |
63,600
+1,700
| +3% | +$25.6K |
|
1703
Metallus
MTUS
$902M
| $1.16M | ﹤0.01% |
43,050
+800
| +2% | +$23.6K |
|
|
ZEN
1704
DELISTED
ZENDESK INC
ZEN
| $1.16M | ﹤0.01% |
52,300
+900
| +2% | +$20.7K |
|
1705
Methode Electronics
MEI
$591M
| $1.16M | ﹤0.01% |
42,100
+800
| +2% | +$35.8K |
|
|
CNSL
1706
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.15M | ﹤0.01% |
54,900
+3,700
| +7% | +$77K |
|
|
TAL
1707
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $1.15M | ﹤0.01% |
36,500
| – | – |
|
1708
UFP Industries
UFPI
$4.96B
| $1.15M | ﹤0.01% |
66,300
+1,500
| +2% | +$27.5K |
|
|
CLDT
1709
Chatham Lodging
CLDT
$581M
| $1.15M | ﹤0.01% |
43,400
+1,600
| +4% | +$45K |
|
|
INSY
1710
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.15M | ﹤0.01% |
32,000
+1,000
| +3% | +$31.1K |
|
1711
Federal Signal
FSS
$7.7B
| $1.15M | ﹤0.01% |
77,000
+1,900
| +3% | +$29.5K |
|
1712
TriNet
TNET
$3B
| $1.14M | ﹤0.01% |
44,900
+800
| +2% | +$25K |
|
|
WIBC
1713
DELISTED
WILSHIRE BANCORP INC
WIBC
| $1.14M | ﹤0.01% |
90,100
+2,900
| +3% | +$32.2K |
|
1714
Renasant Corp
RNST
$3.93B
| $1.13M | ﹤0.01% |
34,800
+1,200
| +4% | +$36.6K |
|
|
TCF
1715
DELISTED
TCF Financial Corporation Common Stock
TCF
| $1.13M | ﹤0.01% |
34,100
+1,000
| +3% | +$31.6K |
|
|
BGC
1716
DELISTED
General Cable Corporation
BGC
| $1.13M | ﹤0.01% |
57,100
+1,100
| +2% | +$20.5K |
|
1717
Aaon
AAON
$6.94B
| $1.13M | ﹤0.01% |
74,925
+1,200
| +2% | +$19K |
|
1718
Merit Medical Systems
MMSI
$5.37B
| $1.12M | ﹤0.01% |
52,000
+1,800
| +4% | +$36.5K |
|
1719
Hecla Mining
HL
$12.1B
| $1.12M | ﹤0.01% |
425,137
+9,100
| +2% | +$28K |
|
1720
Smith & Wesson
SWBI
$639M
| $1.12M | ﹤0.01% |
87,557
| – | – |
|
|
MTSC
1721
DELISTED
MTS Systems Corp
MTSC
| $1.12M | ﹤0.01% |
16,200
+300
| +2% | +$21.2K |
|
1722
ESCO Technologies
ESE
$7.77B
| $1.11M | ﹤0.01% |
29,700
| – | – |
|
|
LUMO
1723
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.11M | ﹤0.01% |
2,789
+311
| +13% | +$132K |
|
|
SPNC
1724
DELISTED
Spectranetics Corp
SPNC
| $1.11M | ﹤0.01% |
48,300
| – | – |
|
1725
Insperity
NSP
$1.89B
| $1.11M | ﹤0.01% |
43,600
-9,800
| -18% | -$256K |
|
Similar funds
Swiss National Bank's Q2 2015 Portfolio in Review
As of Q2 2015, Swiss National Bank held 2,650 positions worth $38.6B, up 3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $1.55B of net new capital in Q2 2015, opening 104 new positions and adding to 1,775 existing holdings. Its largest new stake was Aramark: 434,198 shares worth $9.71M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Qualcomm, an estimated $52.7M trimmed.
- Swiss National Bank's largest Q2 2015 buy was Aramark: 434,198 shares worth $9.71M.
- Swiss National Bank added most to Apple in Q2 2015, an estimated $62.7M increase.
- Swiss National Bank's biggest Q2 2015 reduction was Qualcomm, cutting an estimated $52.7M.
- Swiss National Bank fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $35.8M.
- Swiss National Bank's ten largest holdings make up 14% of its $38.6B portfolio in Q2 2015.
- Swiss National Bank opened 104 new positions and closed 70 in Q2 2015.
- Swiss National Bank's portfolio value rose 3% quarter-over-quarter to $38.6B.
Based on Swiss National Bank's 13F filing for Q2 2015, filed 5 Aug 2015.